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Abstract
Background: Relapse after treatment for anorexia nervosa (AN) is a significant clinical problem. Given the level of
chronicity, morbidity, and mortality experienced by this population, it is imperative to understand the driving forces
behind apparently high relapse rates. However, there is a lack of consensus in the field on an operational definition
of relapse, which hinders precise and reliable estimates of the severity of this issue. The primary goal of this paper
was to review prior studies of AN addressing definitions of relapse, as well as relapse rates.
Methods: Data sources included PubMed and PsychINFO through March 19th, 2016. A systematic review was
performed following the PRISMA guidelines. A total of (N = 27) peer-reviewed English language studies addressing
relapse, remission, and recovery in AN were included.
Results: Definitions of relapse in AN as well as definitions of remission or recovery, on which relapse is predicated,
varied substantially in the literature. Reported relapse rates ranged between 9 and 52%, and tended to increase
with increasing duration of follow-up. There was consensus that risk for relapse in persons with AN is especially
high within the first year following treatment.
Discussion: Standardized definitions of relapse, as well as remission and recovery, are needed in AN to accelerate
clinical and research progress. This should improve the ability of future longitudinal studies to identify clinical,
demographic, and biological characteristics in AN that predict relapse versus resilience, and to comparatively
evaluate relapse prevention strategies. We propose standardized criteria for relapse, remission, and recovery, for
further consideration.
Keywords: Anorexia nervosa, Treatment, Outcome, Relapse, Remission, Recovery, Prevention, Eating disorder,
Bulimia nervosa
Plain English Summary
Relapse occurs frequently in individuals receiving treat-
ment for anorexia nervosa. However, there is no com-
mon agreement on how to define relapse. In this study,
we reviewed previous studies of relapse, remission, and
recovery following treatment for anorexia nervosa. We
found that there were many different definitions for
these terms, which resulted in different estimates of re-
lapse rate. To understand what drives relapse it is
important to have a consistent definition across studies.
To help this discussion we propose common criteria for
relapse, remission, and recovery from anorexia nervosa.
Background
Anorexia nervosa (AN) is a serious psychiatric illness
with amongst the highest mortality rates of any mental
disorder—up to 18% in long-term follow-up studies [1–
3]. Most cases emerge during adolescence, and tend to-
wards a protracted and chronic course [4, 5]. In females,
AN has a point prevalence of 0.3–1.0% and lifetime
prevalence of 1.2–2.2% [6]. Treatment often succeeds in
temporarily restoring weight, but AN individuals are at
an exceedingly high risk for early relapse [7], and
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upwards of 50% relapse within the first year after suc-
cessful hospital treatment [8]. The current lack of robust
and reliable responses to treatment highlights the need
for an improved ability to predict illness trajectories.
The primary focus of this review is on how relapse is
defined following treatment for AN. Since relapse is typ-
ically defined relative to recovery and remission, we also
consider how recovery and remission are defined. Pike
has previously eloquently reviewed relapse, recovery, re-
mission, and response in AN [8]. However, since then 11
studies have addressed this topic. The current review
therefore incorporates these additional publications.
In preparing this review, a lack of clarity and uniform-
ity with regard to how to best define relapse, recovery,
and remission was apparent. This perspective is rein-
forced by a literature review of remission in eating disor-
ders concluding that the definitions and associated rates
vary considerably [9]. Fifteen years ago, a European col-
laboration of experts (COST Action B6) adapted defini-
tions for relapse, recovery, partial and full remission, and
recurrence from the depression literature to AN and bu-
limia nervosa (BN) [10]. Despite rigorous consensus-
building and empirical testing of 233 inpatients with
AN, these criteria have not been uniformly adopted by
the field. To date there are no consensus guidelines
available for clinicians or researchers at the professional
or institutional level providing standardized operational
definitions of relapse, recovery, or remission in AN. This
is limiting. A greater consensus regarding the definition
of these constructs would be of considerable benefit to
clinicians, researchers, patients, and family members, by
allowing all constituents to speak the same language.
We performed a focused review of the extant litera-
ture with the primary aim of examining how these
terms have been defined, in order to improve defini-
tions of relapse, recovery and remission in AN.
Reviewing relapse rates was a secondary goal. We
propose a set of standardized criteria for relapse, re-
covery, and remission from AN, which are internally
cohesive and can facilitate longitudinal assessment by
clinicians and researchers.
Methods
Search and study selection
We conducted a systematic qualitative review according
to the PRISMA guidelines, searching the PubMed and
PsychINFO databases. We used keywords for either “an-
orexia nervosa” or “eating disorders” along with “re-
lapse,” or “recovery,” or “remission.” We used an open
search procedure. We also performed the same searches
on Google Scholar to locate relevant articles that the other
search methods possibly overlooked (none were identi-
fied). Our search covered articles that were published
from 1975 to March 19th, 2016. Titles and abstracts were
evaluated and full text was reviewed for relevant stud-
ies. References sections were screened manually for add-
itional studies unidentified via database search.
Eligibility criteria
Participants had to meet ICD-10, DSM-III, IV, or 5 diag-
nostic criteria for AN for inclusion. Studies (n = 1) focus-
ing on binge eating providing relevant information
regarding relapse risk in AN or treatment outcomes of
AN were also included. Studies examining BN and AN
were included, but not those focused solely on BN (n =
2) (except for one [11] that provided treatment informa-
tion pertinent to AN binge-purge (AN-BP) subtype).
Omitted studies included those focused on unspecified
eating disorders (n = 2), comorbid psychiatric disorders
(n = 2), or those without clinical descriptions of relapse
or recovery (n = 3). Non-English language articles were
excluded (n = 6).
Data review and study quality assessment
Three authors (LCP, SSK, and JF) independently ex-
tracted the following data from the selected studies: first
author, publication year, country, and whether the study
was related to relapse, recovery, or remission. To evalu-
ate the quality of the studies, we performed a systematic
review of each article using the National Heart, Lung,
and Blood Institute Study Quality Assessment Tool [12].
This tool provides a rating checklist for each study type.
Three authors (LCP, DM, SSK) independently evaluated
each study according to the rating checklist, and ren-
dered a rating of “Good” or “Fair” or “Poor.” Study qual-
ity was determined by comparing ratings agreement,
with consensus required among reviewers. Discrepancies
in study quality rating were reconciled via discussion of
the individual items on the ratings checklist to arrive at
consensus agreement on the quality indicator. Disagree-
ments were resolved through discussion and consensus.
There were no biases or poor methods identified that
warranted exclusion from the review.
Results
We identified 27 studies meeting eligibility criteria (see
Fig. 1). An overview of pertinent study characteristics
and definitions of recovery/remission and relapse in AN
are listed in Tables 1 and 2. Definitions of relapse were
fundamental to understanding the reported rates in
these studies. Our review revealed widely varied defini-
tions of relapse and recovery/remission in AN. Defini-
tions of recovery and remission are reviewed first since
relapse is predicated upon them.
Definitions of recovery and remission
Recovery typically requires an extended period of time
during which minimal or no criteria for the disorder are
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met, whereas remission requires a shorter duration [13].
The literature can roughly be divided into articles that
(1) define remission/recovery based solely on weight
measurement, (2) define remission/recovery based solely
on symptom reports, (3) define remission/recovery
based solely on weight and symptom reports, i.e., diag-
nostic criteria available at the time. We briefly review
these studies next (Table 1 lists studies providing defini-
tions of partial remission, full remission, and recovery).
Several studies used body mass index (BMI) as the
only criterion for recovery. Cutoffs included a BMI
above 19 [14] or 20 [7, 15]. In contrast, some described
remission based solely on psychiatric symptoms. In one,
full remission was defined as an absence of all symptoms
or only “residual symptoms” for at least 12 weeks, and
partial remission was defined as a reduction of symp-
toms to a sub-diagnostic level for at least 12 weeks [16].
Adopted from the MacArthur guidelines for depression
[13], Keel et al. [17] defined full remission as a Psychi-
atric Status Rating (PSR) score of ≤2 for 8 weeks. Clau-
sen [18] used the same score for 12 weeks, and defined
partial remission as a PSR ≤3 for 12 weeks.
Other articles described outcomes in terms of body
weight and menstruation, using terminology such as
“good,” “intermediate,” “poor,” or “died” [19–22]. These
criteria, or modifications of them, are often referred to
as the “Morgan-Russell” criteria [19]. A later version
specified remission as weight ≥85% of ideal body weight,
regular menses, and no bingeing or purging behaviors
[23]. Modifying these criteria, recovery was later defined
as not meeting AN DSM-IV-TR criteria for a minimum
of 8 weeks [24].
Several proposed definitions included both weight and
clinical symptoms. Pike [8] defined remission as ≥90% of
ideal body weight, resumption of menses, absence of
compensatory behaviors, and Eating Disorder Examin-
ation (EDE) [25] subscales within 2 standard deviations
(SD) of normal. Recovery was defined as meeting remis-
sion criteria for at least 8 weeks. Strober et al. [4] de-
fined full recovery as the absence of all criteria for at
least 8 weeks, and partial recovery as a “good outcome”
(weight within 15% of average and normal menstruation)
from the Morgan-Russell criteria [19]. Other studies did
not have a duration criterion for the absence of symp-
toms but used the “good outcome” criteria to define re-
covery [20–22]. Stice’s Eating Disorder Diagnostic Scale
defined remission as BMI ≥17.5, regular menses, and no
subthreshold or full threshold eating disorder [26, 27].
Martin [28] defined recovered as having a global rating
scale of “excellent,” meaning an individual was >90%
ideal weight, had regular menstruation, and normal eat-
ing and social patterns. Eckert et al. [29] defined “recov-
ered” as within 15% of ideal body weight, cyclical
menses, and no significant disturbance in eating or
weight control behaviors or body image disturbance.
Kordy et al. [10] defined full recovery for restricting AN
as a BMI >19 and no extreme fear of weight gain for
12 months (plus no purging and no binges for 12 months
Fig. 1 Prisma diagram
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Table 1 Definitions of recovery and remission, according to individual studies identified by the literature search
Authors Criteria Duration Study quality
Definitions of Recovery
Martin, 1985 [28] “Excellent”: > 90% of their ideal weight, regular
menstrual patterns, and eating and social patterns were
normal
Not specified Fair
Norring and Sohlberg, 1993 [34] “Well” defined as having no eating disorder diagnosis
or remnants of the weight and/or shape preoccupation
Not specified Good
Eckert et al., 1995 [29] ≥85% of ideal body weight, cyclical menses, and no
significant disturbance in eating or weight control
behavior or body image disturbance
Not specified Good
Strober et al., 1997 [4] Free of all criterion symptoms of anorexia nervosa or
bulimia nervosa
8 weeks Good
Fichter and Quadflieg, 1999 [21] Outcome “good” defined using Morgan-Russell criteria Not specified Fair
Pike, 1998 [8] ≥90% of ideal body weight or BMI ≥20, resumption of
menses, absence of binge eating or compensatory
behaviors, Eating Disorder Examination subscales within
2 SD of normal
8 weeks Fair
Herzog, et al., 1999 [32] Absence of all symptoms or 1–2 residual symptoms—
Psychiatric Status Rating (PRS) score of 1 or 2
8 weeks Good
Lowe et al., 2001 [22] Outcome “good” defined using Morgan-Russell and PSR 1 Not specified Good
Kordy et al., 2002 [10] AN-R: BMI > 19, no extreme fear of weight gain
AN-BP: BMI > 19, no extreme fear of weight gain, no
vomiting or laxative abuse, no binges
12 months Good
Carter et al., 2004 [15] BMI above 20 Not specified Good
Walsh et al., 2006 [14] BMI above 19 No information Good
Eisler et al., 2007 [20] Outcome “good” defined using Morgan-Russell criteria Not specified Good
Bodell and Mayer, 2011 [24] No DSM–IV criteria of AN 8 weeks Fair
Bardone-Cone et al., 2010 [30] Full recovery: BMI≥ 18.5, absence of binge-eating,
purging or fasting for at least 3 months, not meeting
criteria for current eating disorder, all EDE-Q subscales
within 1 SD of normal
Partial recovery: same as above, but not needing to
satisfy EDE-Q criterion
Not specified Good
Carter et al., 2012 [7] BMI of 20 and reported no more than one BP episode
before the end of treatment.
2 weeks BMI and no BP
behaviors over the previous
28 days at the end of treatment
Good
Definitions of Full Remission
Morgan and Hayward, 1988 [23] ≥85% of ideal body weight, regular menses, and no
binge eating or purging behaviors
Not specified Fair a
Pike, 1998 [8] ≥90% of ideal body weight or BMI ≥20, resumption of
menses, absence of binge eating or compensatory
behaviors, EDE subscales within 2 SD of normal
Not specified Fair
Stice et al., 2000 [27] BMI ≥17.5, regular menses, and no current
subthreshold or full threshold eating disorder
Not specified Good a
Kordy et al., 2002 [10] AN-R: BMI > 19, no extreme fear of weight gain
AN-BP: BMI > 19, no extreme fear of weight gain, no
vomiting or laxative abuse, no binges
12 weeks Good
Keel et al., 2005 [17] Absence of all symptoms or 1–2 residual
symptoms—PSR score ≤2
8 weeks Good
Clausen, 2008 [18] PSR score ≤2 12 weeks Good
Helverskov et al., 2010 [16] Absence of all symptoms/1–2 Residual symptoms—PSR
score of 1 or 2
12 weeks Good
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Table 1 Definitions of recovery and remission, according to individual studies identified by the literature search (Continued)
Definitions of Partial Remission
Lowe et al., 2001 [22] Outcome “improved” defined using Morgan-Russell
criteria and PSR 2, 3, or 4
Not specified Good
Kordy et al., 2002 [10] AN-R: BMI > 17.5
AN-BP: BMI > 17.5 in addition to ≤1 binge per week
and no vomiting or laxative abuse
4 weeks Good
Clausen, 2008 [18] PSR score ≤3 12 weeks Good
Helverskov et al., 2010 [16] PSR score of 3 12 weeks Good
a No NHLBI systematic criteria available to rate this study type; quality rating reflects consensus agreement between two rater assessments
Table 2 Definitions of relapse, according to individual studies identified by the literature search
Authors Criteria Duration Study quality
Definitions of Relapse
Isager et al., 1985 [33] Loss of ≥15% of weight acquired during course of
treatment (if resulting in weight ≤50 kg)
Any point in time within a 1 year
period
Good
Martin, 1985 [28] If the patient required further psychiatric treatment
after discharge during follow–up period
Not specified Fair
Norring and Sohlberg, 1993 [34] “Ill” defined as having an eating disorder Not specified Good
Eckert et al., 1995 [29] Loss of ≥15% of average body weight (based on
Metropolitan Height-Weight Chart, 1959), after
achieving normal body weight
Any point after achieving normal
weight during inpatient treatment
or the follow up period
Good
Strober et al., 1997 [4] Full (“syndromal”) relapse: weight <85% of ideal body
weight and recurrence of psychological symptoms
Partial (“subsyndromal”) relapse: recurrence of psycho-
logical symptoms but ≥85% of ideal body weight
Not specified Good
Fichter and Quadflieg, 1999 [21] Outcome “poor” defined using Morgan-Russell criteria Not specified Fair
Pike 1998 [8] BMI≤ 18.5 or weight ≤85% of ideal body weight; a
minimum 1 SD increase on the Eating Disorder Evaluation;
loss of menstrual functioning if it has been previously
normal; increase in restriction leading to weight loss;
and possibly increased binge eating, compensatory
behavior, or associated medical problems
Not specified Fair
Herzog, et al., 1999 [32] Return to full criteria symptoms and/or Psychiatric
Status Rating (PSR) score of 5 or 6
8 weeks following a state of full
recovery
Good
Lowe et al., 2001 [22] Outcome “poor” defined using Morgan-Russell criteria
and PSR score of 5 or 6
Not specified Good
Kordy et al., 2002 [10] Change from partial or full remission to full syndrome
according to DSM-IV
Not specified Good
Carter, et al., 2004 [15] BMI below 17.5 and/or at least one episode of binge
eating/purging behavior per week
3 consecutive months Good
Keel, et al., 2005 [17] Return to full criteria symptoms and/or PSR score of 5 or 6 Not specified Good
Walsh et al., 2006 [14] BMI below 16.5 for 2 consecutive weeks, or severe
medical complications, or risk of suicide, or development
of another psychiatric disorder requiring treatment
2 consecutive weeks (low BMI) Good
Eisler et al., 2007 [20] Outcome “poor” defined using Morgan-Russell criteria Not specified Good
Clausen, 2008 [18] PSR score ≥3 3 months Good
Bodell and Mayer, 2011 [24] Poor outcome, BMI ≤18.5 (using modified Morgan-
Russell criteria)
Not specified Fair
Helverskov, et al., 2010 [16] Return to full criteria symptoms and/or PSR score of 5 or 6 Not specified Good
Carter et al., 2012 [7] BMI < 17.5 or at least one episode of binge eating/
purging behavior per week
3 consecutive months Good
McFarlane et al., 2015 [31] AN: BMI < 18.5
AN-BP: average 4 episodes of bingeing and/or vomiting
per month, or BMI < 18.5
3 consecutive months Good
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for AN-BP). They defined full remission for both sub-
types as meeting the same criteria for 3 months. Partial
remission was a BMI >17.5 and ≤1 binge per week and
no vomiting or laxative abuse for 1 month in AN-BP.
Another proposed definition of full recovery was a BMI
≥18.5, absence of binging, purging, or fasting for at least
3 months, not meeting criteria for a current eating dis-
order, and all EDE-Questionnaire (EDE-Q) subscales
within 1 SD of normal [30]. They defined partial recov-
ery as the same without the EDE-Q criterion.
Definitions of relapse
Different definitions of relapse were identified (see
Table 2). Some definitions were dependent on weight or
BMI measures including: BMI < 16.5 for 2 weeks [14],
and BMI < 17.5 [7, 15] or <18.5 [31] for three consecu-
tive months. Other definitions included 15% loss of aver-
age body weight after achieving normal body weight,
either during the index hospitalization or any time dur-
ing the 10-year follow-up period [29]. Strober et al. [4]
similarly defined relapse as <85% ideal body weight,
which could occur post-discharge or post-recovery. Fur-
thermore, relapse could be partial if the individual had
recurrence of psychological symptoms but sustained
85% of ideal weight, or full relapse if both psychological
symptoms returned and body weight dropped to less
than 85%. Several groups [19–22, 24] defined relapse as
Morgan-Russell criteria of “poor” (BMI ≤18.5).
Other definitions of relapse were dependent on psy-
chiatric symptoms or a combination of psychiatric
symptoms and weight changes. Kordy et al. [10] used
a definition of change from DSM-IV partial or full re-
mission to full syndrome. Clausen [18] defined relapse
as PSR ≥ 3 or PSR ≤ 2 after 3 months remission. Re-
lapse has also been defined as meeting full syndrome
criteria (PSR ≥ 5) after 8 weeks of remission [17, 32]
and after 12 weeks of remission [16]. Pike’s [8] more
in-depth definition of relapse includes weight loss,
EDE increase, medical issues, and a return of disor-
dered eating, whereas Martin’s [28] is the simplest,
requiring only that an individual needs psychiatric
intervention.
Rates of Relapse
Relapse rates of AN were highly variable ranging from a
low of 9% to a high of 52% following treatment, with the
majority of studies reporting rates greater than 25% [4,
7, 10, 14–18, 21, 22, 24, 28, 29, 32–34]. Studies suggest
that adolescents [4, 20, 28] and individuals with restrict-
ing subtype AN [7, 29] have a lower likelihood of re-
lapse. The first year is the most critical, with particular
risk of relapse occurring as early as 3 months post-
treatment [4, 7, 15, 32]. Not surprisingly, those who re-
cover fully have lower relapse rates (9%) than those who
only partially recover (35%) [10]. Together, these results
suggest that while most patients experience brief epi-
sodes of recovery, a large proportion relapse. Moreover,
the risk is particularly high within the first year.
Follow-Up Variability
There was substantial variability in the literature for
follow-up procedures. Initial evaluation time points
ranged from 4 weeks to 17 months post-treatment [4, 7,
14, 15, 17, 20, 28, 32, 35]. Some studies utilized only a
single follow-up time point [15, 28], whereas others
followed patients across multiple time points [4, 7, 14,
17, 20, 32, 35]. Some studies had regular follow-up visits
(e.g., every 4 weeks [14], 3 months [7]), whereas others
had irregularly spaced follow-ups (e.g., 2, 6 and 12 year
follow up [35]).
Variable follow-up intervals could complicate estima-
tions of relapse rates, since relapse rates can vary by dur-
ation of the study follow-up. According to this view,
shorter follow-up durations might be associated with
lower relapse rates than longer durations. We identified
articles supporting this possibility. For example, relapse
in a study measuring at 6 months was lower (9% for fully
recovered and 35% for partially recovered) [10] versus
studies measuring at 1-year (27–70%) [7, 14] (see
Table 3). Relapse rates also varied by remission criteria,
with stricter remission criteria displaying lower relapse
rates than less stringent criteria. This is evidenced by
two 10-year longitudinal studies. Eckert and colleagues
[29] reported higher relapse rates (42%) with less strin-
gent relapse criteria and Strober and colleagues [4] re-
ported lower relapse rates (29.5%) with stricter relapse
criteria.
Discussion
The main finding of this review is that there are almost
as many definitions of relapse, remission, and recovery
as there are studies of them. To help rectify this state of
affairs, we suggest that the eating disorders research and
clinical communities evaluate, test, and ultimately adopt
standardized definitions for relapse, remission, and re-
covery. Depression [13], bipolar disorder [36], and
schizophrenia [37] researchers already utilize standard-
ized definitions of these constructs. Consensus guide-
lines for response, partial response, remission, recovery,
and relapse in obsessive compulsive disorder were also
recently proposed [38]. However, we could identify no
such definitions for AN across organizational websites,
including: the Academy for Eating Disorders, Eating Dis-
orders Research Society, National Eating Disorders As-
sociation, and the European Council on Eating
Disorders.
Standardizing how relapse and recovery are defined in
research could substantially improve our understanding
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of the pathophysiology of AN and help ground studies
of efficacy and effectiveness, as argued previously [39,
40]. Consensus would increase the quality of meta-
analytic studies. It would facilitate multi-site compari-
sons, which are necessary to improve statistical power for
studying this relatively rare condition. Precise and consist-
ent terminology would also enhance communication
amongst researchers, clinicians, and caregivers.
We propose a unifying framework with potential defi-
nitions for recovery, remission, and relapse to energize
the discussion (see Fig. 2). These definitions are intern-
ally logical, consistent, and conducive to longitudinal
assessment of AN. We advocate the adoption of stan-
dardized definitions for partial and full recovery and
partial and full relapse. DSM-5 defines partial and full
remission, but not partial or full recovery, and the dur-
ation requirement is vague (“a sustained period”) [41].
We propose that definitions of relapse in AN should en-
compass both clinical symptoms and signs such as BMI
measures,1 as has been proposed for definitions of re-
covery [42], to more comprehensively capture the dis-
order. Importantly, our suggested criteria for recovery,
remission, and relapse include objective measures (BMI;
observable behaviors of restricting, binging, and pur-
ging), subjective measures (fear of gaining weight, dis-
turbance of body image), standardized ratings (EDE),
and specific durations of follow-up (1, 3, 6, and
12 months) that are conducive to utilization across both
clinical and research settings (see Fig. 3).
It is worth noting that the proposed approach shares
certain similarities with previous efforts to identify pat-
terns of recovery in AN. For example, the Psychiatric
Status Rating (PSR) scale represented a single six-item
clinician rating based on DSM-III criteria [43]. Lower
scores on this scale, such as a 1, indicated ‘usual self ’ or
the absence of meeting diagnostic criteria, whereas
higher scores, such as a 6, indicated presence of ‘definite
criteria, severe.’ The PSR is similar to our proposed
Fig. 2 Proposed standardized definitions of relapse, remission, and recovery. These standardized definitions were synthesized from the different
criteria for relapse, remission, and recovery in individual studies identified by our systematic review. We include a graphical representation of
these definitions as a useful heuristic tool for conceptualizing the major transition points (relapse in red, remission in yellow, recovery in green)
while at the same time underscoring the continuum of pathology existing within each stage. Note 1: since weight and height normally increase
until age 20 in pediatric and adolescent populations, age- and gender- adjusted BMI percentiles for determining expected body weight (EBW) are
more appropriate in these subgroups, as demonstrated by [52]. Note 2: determination of ideal body weight is complex, and subject to consideration
of racial, ethnic, demographic, and cultural factors [53]. Note 3: Symptoms and behaviors are discrete variables, which are rated/ascertained by the
clinician based on all available clinical information
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approach in the sense that both require clinician ratings,
and both load upon features of AN that are relevant to
diagnostic criteria in terms of weight status, symptom
burden, and ongoing behaviors. However, our proposed
criteria diverge principally with respect to (1) a focus on
defining stages of relapse, remission, and recovery, (2)
reliance upon a standardized and clinically validated
interview (EDE), and (3) utilization of terminology (par-
tial or full relapse, partial or full remission, partial or full
recovery) that are transparent and can be utilized uni-
formly with patients, caregivers, and clinicians. Our EDE
cutoff selection for partial relapse (greater than or equal
to 2 SD below normal) is also consistent with the ‘cutoff
point a,’ which as previously suggested by Jacobsen et al.
[44], represents a conservative and stringent approach to
determining clinically significant changes.
Due to the highest risk of relapse being in the first
year [4, 17, 20, 32, 33] and relapse often occurring as
early as 3 months post-treatment [4, 7, 15, 32], we rec-
ommend that longitudinal studies conduct follow up as-
sessments no less than every 3 months for the first year,
and every 6 months thereafter for longer studies. With-
out standardized definitions, a refined understanding of
the specific outcomes posed by putative risk factors, and
guidance on measurement, we are in danger of adding
more variability to this literature. Clinically, standardized
definitions for relapse, remission and recovery, com-
bined with consistent monitoring, would help provide
consistent and relevant feedback to patients and family
members regarding their level of risk.
There are several important limitations to consider
when interpreting this review. There is an inherent diffi-
culty identifying the true risk factors predicting AN re-
lapse given the disparate definitions of relapse and
recovery provided to date, potentially giving our review
the appearance that it is challenged by a lack of synthe-
sis. We argue that this challenge is precisely what future
studies would overcome by adopting and adhering to
one set of standards. Secondly, our interpretations are
restricted to the somewhat obvious conclusions that AN
is: (1) characterized by high relapse rates, (2) that re-
lapse rates increase with follow-up lengths, and (3)
there are few reliable predictors. While it seems nearly
impossible to glean generalizations from such hetero-
geneous findings, this highlights the necessity for con-
sensus and standardized definitions. It is important to
emphasize that while the current review has focused
on AN, based in part, on our own research efforts, we
believe that similar consensus standards are needed for
other eating disorders such as bulimia nervosa, binge
eating disorder, and unspecified eating disorder. Al-
though advancing such definitions are beyond the
scope of our qualitative review, we hope that highlight-
ing this disparity will provoke further discussion and
progress. Finally, adding a meta-analytic approach
could derive ‘quantitative data’ characterizing out-
comes, but at this point, would not be additively in-
formative given the aforementioned limitations. This
approach would be useful for a future analysis of ag-
gregated studies using uniform definitions.
Fig. 3 Illness trajectories across a 2 year time period for three hypothetical individuals with AN exhibiting different illness courses. One individual
with an uncomplicated course shows a consistent transition from full relapse to full remission to full recovery. Another individual shows a complicated
course marked by partial remission, partial relapse, and partial recovery, followed by a decline to full remission. A third individual shows a complicated
course with no recovery marked by intermittent bouts of full relapse punctuated by partial relapse and partial remission. For an analogous depiction of
illness trajectory based on actual patients, see Kordy et al., [10]
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The value of reaching consensus
It will be important to carefully consider the value of
reaching consensus on definitions of relapse, remission,
and recovery, who will benefit, and how a consensus
would be best achieved. It is hard to imagine a lasting
consensus without the support of eating disorder organi-
zations. These include organizations which are science-
oriented (e.g., Eating Disorder Research Society (EDRS)
[45], Academy for Eating Disorders (AED) [46] Euro-
pean Council on Eating Disorders (ECED) [47]),
clinician-oriented (AED, National Eating Disorders As-
sociation (NEDA) [48], and International Association of
Eating Disorders Professionals (IAEDP) [49]), and pa-
tient and caregiver-oriented (e.g., Families Empowered
and Supporting Treatment of Eating Disorders (FEAST)
[50], National Alliance on Mental Illness (NAMI) [51],
AED, and NEDA).
It is also necessary to prospectively consider the po-
tential challenges to achieving a consensus. In this
regard, the highly interdisciplinary perspectives required
in the research and treatment of eating disorders
(pediatrics, family medicine, psychiatry, psychology, nu-
trition and dietetics, social work, licensed therapy and
counseling, and nursing) results in complex and often
diverging multifactorial models, which risks a fracturing
of consensus regarding these conditions.
Concrete suggestions for harmonizing this discussion
include (1) the development of conference symposia, (2)
cross-organization workgroups or task forces, and (3)
the generation of consensus statements focused on the
topic. Other practical considerations include feasibility
assessments. For example, follow up frequency will al-
ways be of concern, and conducting monthly, quarterly,
and perhaps even bi-annual follow-ups requires re-
sources that may be infeasible for certain research
groups. We would argue that follow up assessment oc-
curring at any frequency should use a standardized ap-
proach that is comparable to other laboratories. In-
person assessments might be supplemented by phone in-
terviews, and/or the remote collection of collateral infor-
mation from family members, and we observed evidence
of this pragmatic approach in the literature surveyed in
this paper.
Conclusion
The heterogeneity and severity of AN presentation poses
challenges to understanding why relapse occurs, and
how to prevent it. We posit that the eating disorders
community will benefit from considering, testing, and
adopting standardized definitions for relapse, remission,
and recovery. To galvanize this movement, we have
attempted to provide a unifying framework with internally
logical and consistent definitions. This framework is con-
ducive to longitudinal clinical and research assessment,
not only for AN, but for bulimia nervosa, binge eating dis-
order, unspecified eating disorder, and other eating disor-
ders. Without consensus, uncertainty and variability in the
reported recovery, remission, and relapse rates will persist.
Standardizing definitions in AN is a critical first step in
identifying at-risk individuals, and can ultimately advance
the development and evaluation of treatments for this life-
threatening illness.
Endnotes
1Since weight and height normally increase until age
20 in pediatric and adolescent populations, age- and
gender- adjusted BMI percentiles for determining ex-
pected body weight (EBW) are more appropriate in
these subgroups (see Le Grange et al., [52]).
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